| 000 | 01633 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250518014934.0 | ||
| 264 | 0 | _c20190528 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1745-6215 | ||
| 024 | 7 |
_a10.1186/s13063-018-3109-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan der Nelson, Helen | |
| 245 | 0 | 0 |
_aIntramuscular oxytocin versus oxytocin/ergometrine versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: study protocol for a randomised controlled trial (the IMox study). _h[electronic resource] |
| 260 |
_bTrials _cJan 2019 |
||
| 300 |
_a4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial Protocol; Journal Article | ||
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aData Collection |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aErgonovine _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 | _aMulticenter Studies as Topic |
| 650 | 0 | 4 | _aOutcome Assessment, Health Care |
| 650 | 0 | 4 |
_aOxytocin _xadministration & dosage |
| 650 | 0 | 4 |
_aPostpartum Hemorrhage _xprevention & control |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aSample Size |
| 700 | 1 | _aO'Brien, Stephen | |
| 700 | 1 | _aLenguerrand, Erik | |
| 700 | 1 | _aMarques, Elsa | |
| 700 | 1 | _aAlvarez, Mary | |
| 700 | 1 | _aMayer, Michelle | |
| 700 | 1 | _aBurnard, Sara | |
| 700 | 1 | _aSiassakos, Dimitrios | |
| 700 | 1 | _aDraycott, Timothy | |
| 773 | 0 |
_tTrials _gvol. 20 _gno. 1 _gp. 4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13063-018-3109-2 _zAvailable from publisher's website |
| 999 |
_c29217912 _d29217912 |
||